Quoin Pharmaceuticals

QNRXNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.620 M

$4.79 +4.81%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$15.8M

Loss-making

Shares outstanding

68,642,195

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#432CytoMed TherapeuticsGDTC$9.71M
#433Lisata TherapeuticsLSTA$9.65M
#434Quoin PharmaceuticalsQNRX$9.62M
#435Lexaria BioscienceLEXX$8.71M
#436ExicureXCUR$8.57M

Where these numbers come from

Share counts and financials for Quoin Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.